Emcure Pharmaceuticals Limited
EMCURE
Quarterly results
Revenue and net profit
₹ crore
Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.
- Income
- ₹ crore
Sept 20261,668
Quarter ₹ crore YoY Sept 2024 1,105 — Dec 2024 1,029 — Mar 2025 1,278 — Jun 2025 1,097 +13.0% Sept 2025 1,261 +14.1% Dec 2025 1,418 +37.9% Mar 2026 1,468 +14.8% Jun 2026 1,451 +32.3% Sept 2026 1,668 +32.3% - ₹ crore
Sept 202634
Quarter ₹ crore Sept 2024 55 Dec 2024 19 Mar 2025 22 Jun 2025 22 Sept 2025 23 Dec 2025 138 Mar 2026 27 Jun 2026 25 Sept 2026 34 - ₹ crore
Sept 20261,702
Quarter ₹ crore Sept 2024 1,160 Dec 2024 1,048 Mar 2025 1,301 Jun 2025 1,118 Sept 2025 1,283 Dec 2025 1,557 Mar 2026 1,495 Jun 2026 1,476 Sept 2026 1,702 - Cost structure
- ₹ crore
Sept 2026231
Quarter ₹ crore Sept 2024 191 Dec 2024 196 Mar 2025 198 Jun 2025 210 Sept 2025 203 Dec 2025 206 Mar 2026 202 Jun 2026 210 Sept 2026 231 - ₹ crore
Sept 20261,369
Quarter ₹ crore Sept 2024 1,040 Dec 2024 981 Mar 2025 1,115 Jun 2025 949 Sept 2025 1,125 Dec 2025 1,213 Mar 2026 1,196 Jun 2026 1,207 Sept 2026 1,369 - Exceptional items and tax
- ₹ crore
Sept 2026332
Quarter ₹ crore Sept 2024 119 Dec 2024 67 Mar 2025 186 Jun 2025 166 Sept 2025 158 Dec 2025 314 Mar 2026 306 Jun 2026 269 Sept 2026 332 - ₹ crore
Sept 202684
Quarter ₹ crore Sept 2024 32 Dec 2024 17 Mar 2025 46 Jun 2025 43 Sept 2025 40 Dec 2025 56 Mar 2026 73 Jun 2026 69 Sept 2026 84 - Profit
- ₹ crore
Sept 2026248
Quarter ₹ crore YoY Sept 2024 87 — Dec 2024 50 — Mar 2025 140 — Jun 2025 123 +203.6% Sept 2025 118 +35.3% Dec 2025 259 +415.6% Mar 2026 234 +67.5% Jun 2026 200 +63.0% Sept 2026 248 +111.2% - Per share
- ₹ per share
Sept 202613.10
Quarter ₹ per share Sept 2024 4.62 Dec 2024 2.65 Mar 2025 7.37 Jun 2025 6.48 Sept 2025 6.21 Dec 2025 13.65 Mar 2026 12.33 Jun 2026 10.55 Sept 2026 13.10
| ₹ crore | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Income | |||||||||
| 1,105 | 1,029 | 1,278 | 1,097 | 1,261 | 1,418 | 1,468 | 1,451 | 1,668 | |
| Revenue YoY | — | — | — | +13.0% | +14.1% | +37.9% | +14.8% | +32.3% | +32.3% |
| 55 | 19 | 22 | 22 | 23 | 138 | 27 | 25 | 34 | |
| 1,160 | 1,048 | 1,301 | 1,118 | 1,283 | 1,557 | 1,495 | 1,476 | 1,702 | |
| Cost structure | |||||||||
| 191 | 196 | 198 | 210 | 203 | 206 | 202 | 210 | 231 | |
| 1,040 | 981 | 1,115 | 949 | 1,125 | 1,213 | 1,196 | 1,207 | 1,369 | |
| Exceptional items and tax | |||||||||
| 119 | 67 | 186 | 166 | 158 | 314 | 306 | 269 | 332 | |
| 32 | 17 | 46 | 43 | 40 | 56 | 73 | 69 | 84 | |
| Profit | |||||||||
| 87 | 50 | 140 | 123 | 118 | 259 | 234 | 200 | 248 | |
| Net profit YoY | — | — | — | +203.6% | +35.3% | +415.6% | +67.5% | +63.0% | +111.2% |
| Per share | |||||||||
| 4.62 | 2.65 | 7.37 | 6.48 | 6.21 | 13.65 | 12.33 | 10.55 | 13.10 | |
Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.